DESOUZA ERROL B
SEC CIK 1213895 · EDGAR
Most active insiders at ALEC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rosenthal Arnon | CEO, Dir | — | $656.1K |
| 2 | Berkley Neil Lindsay | Chief Bus Ofcr, Interim CFO | — | $220.8K |
| 3 | Wong-Sarad Grace | Principal Accounting Off | — | $99.0K |
| 4 | Kenkare-Mitra Sara | Pres, Head of R, D | — | $46.7K |
| 5 | GAROFALO ELIZABETH A. | Dir | — | — |
| 6 | Hammond Paula | Dir | — | — |
| 7 | Yaffe Kristine | Dir | — | — |
| 8 | Altmeyer Mark | Dir | — | — |
| 9 | SCHELLER RICHARD H | Dir | — | — |
| 10 | LAVIGNE LOUIS J JR | Dir | — | — |
| 11 | DESOUZA ERROL B | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-17 16:05 | 2026-06-17 | ALEC | Alector, Inc. | DESOUZA ERROL B | Dir | A - Grant | $0.00 | +28.7K | 98.7K | +41% | $0 |
| D | 2025-06-12 | 2025-06-11 | ALEC | Alector, Inc. | DESOUZA ERROL B | Dir | A - Grant | $0.00 | +28.7K | 70.0K | +70% | $0 |
| 2025-05-14 | 2025-05-13 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Dir | A - Grant | $0.00 | +7,614 | 81.4K | +10% | $0 | |
| 2024-06-10 | 2024-06-07 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Dir | A - Grant | $0.00 | +9,293 | 73.7K | +14% | $0 | |
| D | 2024-03-21 | 2024-03-19 | ALEC | Alector, Inc. | DESOUZA ERROL B | Dir | A - Grant | $0.00 | +41.2K | 41.2K | New | $0 |
| M | 2023-12-04 | 2023-11-30 | KRSA | Korsana Biosciences, Inc. | DESOUZA ERROL B | Dir | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
| 2023-06-26 | 2023-06-23 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Dir | A - Grant | $0.00 | +7,747 | 64.4K | +14% | $0 | |
| 2022-06-24 | 2022-06-24 | RPRX | Royalty Pharma plc | DESOUZA ERROL B | Dir | A - Grant | $0.00 | +6,328 | 56.7K | +13% | $0 | |
| 2021-10-05 | 2021-10-01 | GYRE | GYRE THERAPEUTICS, INC. | DESOUZA ERROL B | Dir | A - Grant | $0.00 | +3,588 | 29.8K | +14% | $0 | |
| D | 2021-07-02 | 2021-07-01 | GYRE | GYRE THERAPEUTICS, INC. | DESOUZA ERROL B | Dir | A - Grant | $0.00 | +3,406 | 26.2K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations